Could increased vascular endothelial growth factor induced by interleukin 17 be the cause of posterior reversible encephalopathy syndrome in systemic lupus erythematosus?

J Rheumatol. 2012 Apr;39(4):870; author reply 871. doi: 10.3899/jrheum.111124.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Interleukin-17 / physiology*
  • Lupus Erythematosus, Systemic / blood
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / physiopathology*
  • Posterior Leukoencephalopathy Syndrome / blood*
  • Posterior Leukoencephalopathy Syndrome / immunology
  • Posterior Leukoencephalopathy Syndrome / physiopathology*
  • Up-Regulation / immunology
  • Vascular Endothelial Growth Factor A / biosynthesis*
  • Vascular Endothelial Growth Factor A / blood

Substances

  • Interleukin-17
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A